

Three weeks ago I wrote about a study comparing a whey-based ready-to-use therapeutic food (RUTF) to a soy-based RUTF in the treatment of moderate malnutrition. The results showed a clear advantage to the whey-based RUTF, with a significantly greater 3.4% recovery rate, despite a markedly lower amount of calories (-8%) and protein (-33%). What’s more, this study showed that this superior product was similarly affordable, costing a mere $1.36 more per child who recovers from malnutrition. Not everyone agrees that this price is affordable. In a recent study by Bahwere et al, it was argued that “the high milk content of this formulation makes it very expensive for sustainable use in resource-poor settings and increases the proportion of ingredients that have to be imported into developing countries.” Accordingly, they conducted a study comparing the efficacy of a RUTF made from soy, maize, and sorghum (SMS-RUTF) to the efficacy of a peanut...











